Madrigal Pharmaceuticals Inc (MDGL) — Net Asset Quality Index
Madrigal Pharmaceuticals Inc (MDGL) has a Net Asset Quality Index of 47.8% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.26 Billion minus total liabilities of $656.90 Million yields net assets of $602.69 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check financial resilience of Madrigal Pharmaceuticals Inc to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Madrigal Pharmaceuticals Inc Net Asset Quality Index Over Time (2001–2025)
This chart shows how Madrigal Pharmaceuticals Inc's Net Asset Quality Index has evolved across 24 annual periods from 2001 to 2025. As of December 2025, the index stands at 47.8%, representing net assets of $602.69 Million against total assets of $1.26 Billion USD. See Madrigal Pharmaceuticals Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Madrigal Pharmaceuticals Inc (2001–2025)
The table below presents the year-by-year Net Asset Quality Index for Madrigal Pharmaceuticals Inc from 2001 to 2025, covering 24 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see MDGL company net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 47.8% | $602.69 Million | $1.26 Billion | $656.90 Million | ▼ -24.5 pp |
| 2024 | 72.4% | $754.38 Million | $1.04 Billion | $287.86 Million | ▲ +9.1 pp |
| 2023 | 63.3% | $405.33 Million | $640.55 Million | $235.21 Million | ▲ +8.8 pp |
| 2022 | 54.4% | $197.39 Million | $362.57 Million | $165.18 Million | ▼ -17.3 pp |
| 2021 | 71.7% | $196.11 Million | $273.33 Million | $77.22 Million | ▼ -11.9 pp |
| 2020 | 83.6% | $239.97 Million | $287.00 Million | $47.02 Million | ▼ -10.6 pp |
| 2019 | 94.2% | $416.56 Million | $442.06 Million | $25.49 Million | ▼ -4.0 pp |
| 2018 | 98.3% | $476.98 Million | $485.43 Million | $8.44 Million | ▲ +3.5 pp |
| 2017 | 94.8% | $182.26 Million | $192.31 Million | $10.05 Million | ▲ +6.4 pp |
| 2016 | 88.4% | $36.41 Million | $41.21 Million | $4.80 Million | ▲ +14.4 pp |
| 2015 | 73.9% | $50.41 Million | $68.19 Million | $17.79 Million | ▲ +9.2 pp |
| 2014 | 64.7% | $65.14 Million | $100.67 Million | $35.54 Million | ▲ +13.1 pp |
| 2013 | 51.6% | $49.09 Million | $95.20 Million | $46.11 Million | ▼ -21.3 pp |
| 2012 | 72.9% | $75.07 Million | $103.02 Million | $27.95 Million | ▲ +38.0 pp |
| 2011 | 34.9% | $14.77 Million | $42.32 Million | $27.55 Million | ▼ -8.5 pp |
| 2010 | 43.4% | $23.48 Million | $54.07 Million | $30.59 Million | ▼ -7.5 pp |
| 2009 | 50.9% | $24.91 Million | $48.91 Million | $24.00 Million | ▲ +111.4 pp |
| 2008 | -60.5% | $-58.79 Million | $97.25 Million | $156.04 Million | ▼ -80.8 pp |
| 2007 | 20.3% | $24.90 Million | $122.65 Million | $97.75 Million | ▲ +23.5 pp |
| 2006 | -3.2% | $-1.75 Million | $54.79 Million | $56.54 Million | ▼ -76.9 pp |
| 2005 | 73.7% | $52.48 Million | $71.21 Million | $18.73 Million | ▼ -15.7 pp |
| 2004 | 89.3% | $117.96 Million | $132.02 Million | $14.06 Million | ▼ -6.3 pp |
| 2003 | 95.7% | $76.89 Million | $80.39 Million | $3.50 Million | ▼ -3.3 pp |
| 2001 | 99.0% | $2.74 Million | $2.77 Million | $29.00K | — |